» Authors » Yujing Chi

Yujing Chi

Explore the profile of Yujing Chi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 30
Citations 1107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Yan H, Liu W, Xiang R, Li X, Hou S, Xu L, et al.
Signal Transduct Target Ther . 2024 Aug; 9(1):214. PMID: 39117631
Nonalcoholic fatty liver disease (NAFLD) is a serious threat to public health, but its underlying mechanism remains poorly understood. In screening important genes using Gene Importance Calculator (GIC) we developed...
3.
Zhang Y, Wu Z, Zhao Q, Liu Y, Huang Q, Zhang M, et al.
Biology (Basel) . 2024 May; 13(5). PMID: 38785804
The pathogenesis of inflammatory bowel disease (IBD) is still unknown. Mesenteric lymphatics (MLs), which are closely related to the intestine in both anatomy and physiology, have been suggested to be...
4.
Yang X, Lin Y, Huang J, Chi Y, Wu Y, Lin S
Sci Rep . 2024 Mar; 14(1):5923. PMID: 38467667
Uric acid (UA) is associated with non-alcoholic fatty liver disease (NAFLD). However, it is unclear whether UA plays a predictive role in NAFLD prognosis. This study aimed to explore the...
5.
Su W, Chi Y, An Y
Front Physiol . 2023 Aug; 14:1266356. PMID: 37637148
No abstract available.
6.
Hu Y, Li J, Li X, Wang D, Xiang R, Liu W, et al.
Metabolism . 2023 Jul; 146:155661. PMID: 37454871
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide; however, the underlying mechanisms remain poorly understood. FAM3D is a member of the FAM3 family; however, its...
7.
Yan H, Meng Y, Li X, Xiang R, Hou S, Wang J, et al.
Metabolism . 2022 Dec; 139:155372. PMID: 36470472
Reduced mitochondrial ATP synthase (ATPS) capacity plays crucial roles in the pathogenesis of metabolic disorders. However, there is currently no effective strategy for synchronously stimulating the expressions of ATPS key...
8.
Liu X, Hou S, Xiang R, Hu C, Chen Z, Li N, et al.
Metabolism . 2022 Aug; 136:155292. PMID: 35995281
Mitochondrial FAM3A has been revealed to be a viable target for treating diabetes and nonalcoholic fatty liver disease (NAFLD). However, its distinct mechanism in ameliorating hepatic steatosis remained unrevealed. High-throughput...
9.
Li J, Yan H, Xiang R, Yang W, Ye J, Yin R, et al.
Front Physiol . 2022 Jul; 13:918042. PMID: 35800345
Diabetes (DM), especially type 2 diabetes (T2DM) has become one of the major diseases severely threatening public health worldwide. Islet beta cell dysfunctions and peripheral insulin resistance including liver and...
10.
Yang X, Cheng Y, Zhou J, Zhang L, Li X, Wang Z, et al.
Adv Sci (Weinh) . 2022 Jan; 9(8):e2104472. PMID: 35064767
Diabetes is closely related to the occurrence of endometrial cancer (EC) and its poor prognosis. However, there is no effective clinical treatment for EC patients with diabetes (patient ). To...